HSBC Holdings’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,309
Closed -$250K 3185
2022
Q4
$250K Sell
13,309
-15,601
-54% -$301K ﹤0.01% 2664
2022
Q3
$517K Sell
28,910
-3,011
-9% -$52.2K ﹤0.01% 2147
2022
Q2
$558K Buy
31,921
+9,485
+42% +$181K ﹤0.01% 2265
2022
Q1
$470K Buy
22,436
+6,268
+39% +$120K ﹤0.01% 2457
2021
Q4
$289K Buy
+16,168
New +$260K ﹤0.01% 2805
2021
Q2
Sell
-23,918
Closed -$437K 3127
2021
Q1
$437K Sell
23,918
-3,788
-14% -$74.8K ﹤0.01% 2066
2020
Q4
$501K Sell
27,706
-1,399
-5% -$22.2K ﹤0.01% 2198
2020
Q3
$375K Buy
29,105
+2,072
+8% +$26.5K ﹤0.01% 2113
2020
Q2
$297K Buy
27,033
+4,232
+19% +$43.8K ﹤0.01% 2131
2020
Q1
$234K Buy
22,801
+11,784
+107% +$152K ﹤0.01% 2200
2019
Q4
$175K Sell
11,017
-165
-1% -$2.73K ﹤0.01% 2843
2019
Q3
$176K Buy
+11,182
New +$186K ﹤0.01% 2901
2017
Q1
Sell
-13,125
Closed -$173K 2668
2016
Q4
$173K Buy
+13,125
New +$168K ﹤0.01% 2556

Other funds holding NXGN

HSBC Holdings's NXGN Position: Q1 2023 in Review

HSBC Holdings sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q1 2023, closing a stake of 13,309 shares — an estimated $250K sold.

HSBC Holdings first reported a position in NXGN in Q4 2016 and held it in 13 quarters. The position peaked at $558K in Q2 2022. 214 funds tracked by Wall St. Rank hold NXGN as of Q1 2023.

  • HSBC Holdings reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • HSBC Holdings sold 13,309 NextGen Healthcare, Inc. Common Stock shares in Q1 2023, an estimated $250K.
  • HSBC Holdings first reported a position in NextGen Healthcare, Inc. Common Stock in Q4 2016 and held it in 13 quarters.
  • HSBC Holdings's NextGen Healthcare, Inc. Common Stock position peaked at $558K in Q2 2022.
  • 214 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q1 2023.

Based on HSBC Holdings's 13F filing for Q1 2023, filed 15 May 2023.